DBV Technologies S.A. (EPA:DBV)
1.542
-0.018 (-1.15%)
Jun 27, 2025, 5:35 PM CET
DBV Technologies Revenue
DBV Technologies had revenue of $753.00K USD in the quarter ending March 31, 2025, a decrease of -46.48%. This brings the company's revenue in the last twelve months to $3.50M, down -76.59% year-over-year. In the year 2024, DBV Technologies had annual revenue of $4.15M, down -73.61%.
Revenue (ttm)
$3.50M
Revenue Growth
-76.59%
P/S Ratio
65.17
Revenue / Employee
$31.79K
Employees
110
Market Cap
210.86M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.15M | -11.58M | -73.61% |
Dec 31, 2023 | 15.73M | 10.88M | 224.69% |
Dec 31, 2022 | 4.84M | -864.00K | -15.14% |
Dec 31, 2021 | 5.71M | -5.57M | -49.38% |
Dec 31, 2020 | 11.28M | -3.43M | -23.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 26.51B |
Sanofi | 45.17B |
Sartorius Stedim Biotech | 2.86B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
Clariane SE | 5.28B |
DBV Technologies News
- 2 days ago - DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old - GlobeNewsWire
- 15 days ago - DBV Technologies to Participate in Upcoming EAACI Congress 2025 - GlobeNewsWire
- 16 days ago - DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting - GlobeNewsWire
- 24 days ago - DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document - GlobeNewsWire
- 5 weeks ago - DBV Technologies files to sell 289M ordinary shares for holders - Seeking Alpha
- 6 weeks ago - Combined General Meeting of June 11, 2025 - GlobeNewsWire
- 6 weeks ago - DBV Technologies: A Great Time To Sell - Seeking Alpha
- 7 weeks ago - DBV Technologies to Participate in the Citizens JMP Life Sciences Conference - GlobeNewsWire